EPIGENETIC ALTERATION OF 11B;HYDROXYSTEROID DEHYDROGENASE 1 IN THE ADIPOSE TISSUE OF PATIENTS WITH ENDOCRINE HYPERTENSION

被引：0

作者：

Takeda, Yoshiyu ^{[1
,3
]}

Takeda, Yoshimichi ^{[2
,3
]}

Demura, Masashi ^{[4
]}

Kometani, Mitsuhiro ^{[2
,3
]}

Karashima, Shigehiro ^{[3
]}

Aono, Daisuke ^{[2
,3
]}

Konishi, Seigo ^{[2
,3
]}

Yoneda, Takashi ^{[3
]}

机构：

[1] Asanogawa Gen Hosp, Kanazawa, Ishikawa, Japan

[2] Kanazawa Univ, Endocrinol & Metab, Kanazawa, Ishikawa, Japan

[3] Kanazawa Univ, Grad Sch Med, Dept Hlth Promot & Med Future, Kanazawa, Ishikawa, Japan

[4] Kanazawa Univ, Dept Hyg, Kanazawa, Ishikawa, Japan

来源：

JOURNAL OF HYPERTENSION | 2023年 / 41卷

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

PS-C21-4

引用

页码：E398 / E399

页数：2

共 50 条

[31] Epigenetic control of hydroxysteroid (11-beta) dehydrogenase 2 gene is related to human hypertension
Pizzolo, F.
Friso, S.
Choi, S. W.
Pavan, C.
Guarini, P.
Castagna, A.
Ravagnani, V.
Lotto, V.
Carletto, A.
Pattini, P.
Corrocher, R.
Olivieri, O.
JOURNAL OF HYPERTENSION, 2007, 25 : S247 - S247
[32] Increased expression of 11β-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in HIV-associated lipodystrophy
Sutinen, J
Kannisto, K
Korsheninnikova, E
Nyman, T
Hamsten, A
Wake, D
Walker, B
Yki-Järvinen, H
ANTIVIRAL THERAPY, 2003, 8 (04) : L8 - L8
[33] 11β-Hydroxysteroid Dehydrogenase Types 1 and 2 Activity in Subcutaneous Adipose Tissue in Humans: Implications in Obesity and Diabetes
Dube, Simmi
Norby, Barbara J.
Pattan, Vishwanath
Carter, Rickey E.
Basu, Ananda
Basu, Rita
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (01): : E70 - E76
[34] Expression and Activity of 11β-Hydroxysteroid Dehydrogenase Type 1 Enzyme in Subcutaneous and Visceral Adipose Tissue of Prepubertal Children
Mericq, Veronica
Medina, Pablo
Bouwman, Carolien
Johnson, M. Cecilia
Godoy, Jorge
Lopez, Teresa
Iniguez, German
HORMONE RESEARCH, 2009, 71 (02) : 89 - 93
[35] Differential Regulation of 11β-Hydroxysteroid Dehydrogenase Type 1 and 2 Enzyme Activities in Subcutaneous Adipose Tissue of Humans
Dube, Simmi
Norby, Barbara
Basu, Ananda
Basu, Rita
DIABETES, 2013, 62 : A513 - A513
[36] Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients
Baudrand, Rene
Miguel Dominguez, Jose
Carvajal, Cristian A.
Riquelme, Arnoldo
Campino, Carmen
Macchiavello, Stefano
Bozinovic, Milan
Morales, Mauricio
Pizarro, Margarita
Solis, Nancy
Escalona, Alex
Boza, Camilo
Arrese, Marco
Fardella, Carlos E.
METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (12): : 1775 - 1780
[37] Inhibition of 11β-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension
Rauz, S
Cheung, CMG
Wood, PJ
Coca-Prados, M
Walker, EA
Murray, PI
Stewart, PM
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2003, 96 (07) : 481 - 490
[38] Endocrine disruptors and other inhibitors of 11β-hydroxysteroid dehydrogenase 1 and 2: Tissue-specific consequences of enzyme inhibition
Vitku, Jana
Starka, Luboslav
Bicikova, Marie
Hill, Martin
Heracek, Jiri
Sosvorova, Lucie
Hampl, Richard
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2016, 155 : 207 - 216
[39] The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11β-hydroxysteroid dehydrogenase type 1 in the adipose tissue of children
J Wang
B Sun
M Hou
X Pan
X Li
International Journal of Obesity, 2013, 37 : 999 - 1005
[40] The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11β-hydroxysteroid dehydrogenase type 1 in the adipose tissue of children
Wang, J.
Sun, B.
Hou, M.
Pan, X.
Li, X.
INTERNATIONAL JOURNAL OF OBESITY, 2013, 37 (07) : 999 - 1005

← 1 2 3 4 5 →